Web12 mar 2024 · The JCOG0212 (ClinicalTrials.gov: NCT00190541, UMIN-CTR: C000000034) RCT was undertaken to confirm the non-inferiority of mesorectal excision (ME) alone compared with ME and LLND in patients with stage II and III rectal cancer without obvious LLN enlargement, in whom CRT is not performed 9. Web― 3 ― 8号 下部直腸癌外科治療の変遷と展望 ―1585― 約筋を切除した手術に対してisrと呼ぶことが世界的 な考え方ではあるが,それでは歯状線より口側の内肛
Challenges needed to be overcome in multi ... - Oxford Academic
Web13 set 2005 · Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer … http://www.jcog.jp/document/0212.pdf how to get your ip pin
Mesorectal Excision With or Without Lateral Lymph Node ... - PubMed
Web1 gen 2014 · In the JCOG0212 trial, however, autonomic nerve-preserving surgery was performed for all of the enrolled patients, thus accounting for the similarity of postoperative urinary and sexual functions between the groups. It is anticipated that the JCOG0212 trial will yield informative data for evaluation of prophylactic lateral lymph node dissection. WebBackground: The JCOG0212 trial was a randomized controlled trial comparing mesorectal excision alone to mesorectal excision with lateral lymph node dissection for stage II/III lower rectal cancer patients without clinical lateral lymph node enlargement. This study aimed to identify clinicopathological prognostic factors for relapse-free survival and overall survival … Web21 gen 2024 · Most evidence regarding lateral lymph node dissection for rectal cancer is from expert settings. This study aimed to evaluate the safety and efficacy of this procedure in a practice-based cohort. A total of 383 patients who were diagnosed with stage II–III mid-to-low rectal cancer between 2010 and 2024 and underwent primary resection with … how to get your ip pin online